The Graft

ALL EPISODES AS VIDEO https://youtu.be/La-723RhDIA CONNECT WITH US https://twitter.com/TheEBMT_Trainee https://www.ebmt.org/trainee-committee https://twitter.com/NicoGagelmann https://twitter.com/Claire_P_Horgan

FOLLOW MLL Twitter: @leukaemielabor mll.com

FOLLOW Daniela Twitter: @HermelinMD https://www.bloodcenter.org/about/news/authors/daniela-hermelin-md-a7/ https://www.blooducation.com/about-dr-hermelin ALL EPISODES AS AUDIO APPLE https://podcasts.apple.com/de/podcast/the-graft/id1543609846 SPOTIFY https://open.spotify.com/show/2x2ovFm0cG0NmgyItygbab GOOGLE https://podcasts.google.com/feed/aHR0cHM6Ly9hbmNob3IuZm0vcy80Mjk1MzA1Yy9wb2RjYXN0L3Jzcw== CONNECT WITH US https://twitter.com/TheEBMT_Trainee https://www.ebmt.org/trainee-committee https://twitter.com/NicoGagelmann https://twitter.com/Claire_P_Horgan

https://twitter.com/AbbasiMuqtadir CONNECT WITH US https://twitter.com/TheEBMT_Trainee https://www.ebmt.org/trainee-committee https://twitter.com/NicoGagelmann https://twitter.com/Claire_P_Horgan

Dr. Brudno researches the use of chimeric antigen receptor (CAR) T-cell therapy to treat cancers of the blood, including Non-Hodgkin lymphoma, Hodgkin lymphoma, acute lymphoblastic leukemia (ALL), and multiple myeloma. Her focus is in the development of phase I clinical trials. She is also interested in patient safety, particularly in optimizing patient safety for cellular immunotherapies. Nico Gagelmann and Jennifer Brudno ALL EPISODES AS AUDIO APPLE https://podcasts.apple.com/de/podcast/the-graft/id1543609846 SPOTIFY https://open.spotify.com/show/2x2ovFm0cG0NmgyItygbab GOOGLE https://podcasts.google.com/feed/aHR0cHM6Ly9hbmNob3IuZm0vcy80Mjk1MzA1Yy9wb2RjYXN0L3Jzcw== CONNECT WITH US https://twitter.com/TheEBMT_Trainee https://www.ebmt.org/trainee-committee https://twitter.com/NicoGagelmann https://twitter.com/Claire_P_Horgan

Cindy Chmielewski (@myelomateacher on Twitter) was diagnosed with  multiple myeloma in July 2008 after suffering for two years with  debilitating back pain which was wrongly attributed to degenerative disc  disease. ALL EPISODES AS AUDIO APPLE https://podcasts.apple.com/de/podcast/the-graft/id1543609846 SPOTIFY https://open.spotify.com/show/2x2ovFm0cG0NmgyItygbab GOOGLE https://podcasts.google.com/feed/aHR0cHM6Ly9hbmNob3IuZm0vcy80Mjk1MzA1Yy9wb2RjYXN0L3Jzcw== CONNECT WITH US https://twitter.com/TheEBMT_Trainee https://www.ebmt.org/trainee-committee https://twitter.com/NicoGagelmann https://twitter.com/Claire_P_Horgan CONNECT WITH MYELOMA ADVOCATES https://healthtree.org/myeloma

Heslop is a professor of medicine and pediatrics and holds the Dan L Duncan Chair at Baylor. She is a physician-scientist engaged in translational research focusing on adoptive immunotherapy with gene-modified effector cells to improve hemopoietic stem cell transplantation and cancer therapy. She has extensive experience in developing and conducting transplant studies and cell and gene therapy studies and currently holds more than 20 Investigational New Drug Applications. She also has played a major role nationally as president of societies focusing on the intellectual and clinical development of cellular therapies and accreditation of facilities delivering cell therapies. Dr. Helen Heslop has been elected to the National Academy of Medicine. She is among 90 regular members and 10 international members announced today at the Academy's annual meeting.

Dr. Mohyuddin completed his medical training at Aga Khan University in Pakistan and his internal medicine residency at the University of Kansas where he developed a passion for medical education and treating hematological malignancies. He completed his fellowship developing a clinical and research interest in multiple myeloma, drug repurposing, quality of scientific methods end of life, cost-effective/evidence based care and medical education. He enjoys the outdoors, and that drew him to life in Utah where he is currently Assistant Professor at the Huntsman Cancer Institute with a focus on multiple myeloma.

Nikita Mehra (@DrNikitaMehra) is an Associate Professor at Medical Oncology and Researcher in Molecular Oncology in the Cancer Institute (WIA), Chennai, India.

Dr. Raffaella Greco (@RaffaellaGrecoM) is a hematologist in the Department of Hematology and Bone Marrow Transplantation at the IRCCS Ospedale San Raffaele under the supervision of Professor Fabio Ciceri. After graduating in 2008 from the Faculty of Medicine and Surgery of the University of Milan Vita-Salute San Raffaele received a specialization in hematology at the same university in 2014. CONNECT WITH US https://twitter.com/TheEBMT_Trainee https://www.ebmt.org/trainee-committee https://twitter.com/NicoGagelmann https://twitter.com/Claire_P_Horgan

Final year hematology fellow: @nihardesai7 Interview: Nico Gagelmann, Claire Horgan CONNECT WITH US https://twitter.com/TheEBMT_Trainee https://www.ebmt.org/trainee-committee https://twitter.com/NicoGagelmann https://twitter.com/Claire_P_Horgan

Anna Sureda is president elect of EBMT

https://www.uicc.org/membership/national-cancer-institute-kiev-ukraine

Assistant Professor, Department of Hematopathology, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX Interview: Nico Gagelmann, Claire Horgan

Dr Toby Eyre is a substantive consultant haematologist at Oxford University Hospitals NHS Foundation Trust specialising in the management of lymphoid malignancies. He is considered a national expert in the management of patients with lymphoma and patients with chronic lymphocytic leukaemia. Twitter: https://twitter.com/TobyEyre82 Interview: Nico Gagelmann

Dr. Birhiray earned a Doctor of Medicine degree from the University of Benin, Nigeria, and completed his Internal Medicine residency at Columbus Hospital (an affiliate of Northwestern University) in Chicago, Illinois. He completed fellowships in Bone Marrow Transplant and Medical Oncology at Johns Hopkins University and The National Cancer Institute in Bethesda, Maryland, respectively. Dr. Birhiray has participated in research and is published on the subjects of immunotherapy, lymphomas and bone marrow transplantation. Dr. Birhiray is a member of The American Society of Clinical Oncology, American Society of Hematology, American Medical Association and the Wisconsin Medical Society. Interview: Nico Gagelmann and Claire Horgan

The following podcast hosts trainees from Latina America, Laura Saavedra from Venezuela, Andres Gomez from Mexico, Rafaela Muratori from Brazil and Susy Bazan from Peru. This recording is the second part, where we discuss shared experiences and challenges. But most of the time, we will listen to them and learn from them. The first part with presentations of each country can be found on our youtube channel: https://youtu.be/fJmv5glG1sY

The following is a conversation with Prof Nada Hamad, a senior staff specialist in bone marrow transplant, clinical and laboratory haematologist at St Vincent's hospital in Sydney, where she is also director of the haematology clinical trials unit. She is President of the Bone Marrow Transplant Society of Australia and New Zealand. She is a senior lecturer at the University of Sydney and University of NSW.

The following is a conversation with Prof Vincent Rajkumar is engaged in clinical, epidemiological and laboratory research in myeloma and related disorders. Dr. Rajkumar served as the principal investigator on several clinical trials for the treatment of myeloma. We talk with him about myeloma, COVID, how he thinks trainees can make sense of all the data out there, access to treatments and drug costs. Interview: Nico Gagelmann, Claire Horgan

This conversation is about cancer and all the overwhelming challenges and potential discrimination that come with the diagnosis, inequalities, death, the impact of COVID, the importance of time and communication, and Chris' unique and inspiring story. His website: www.chris-cancercommunity.com SimPal: https://www.yoursimpal.com/ Interview: Nico Gagelmann

The following is a conversation with Chadi Nabhan, Chairman of Precision Oncology Alliance at Caris Life Sciences. We talk with him about good medicine, the art of being human, actually caring for patients, and the essence of science and its abuse in current times of COVID. With his podcast "healthcare unfiltered", his perspective articles in Journal of Clinical Oncology, JAMA and others, he is a really human voice in an ever challenging environment of pretenders. Previously, Dr. Nabhan was an Associate Professor of Medicine, and Medical Director of the Clinical Cancer Center at the University of Chicago. He also hosts the podcast healthcare unfiltered, talking about all aspects of cancer care, science and medicine. Please check out his podcast and his texts. If you like this episode, feel free to leave feedback and share this video or audio links on spotifiy/apple and others. And now enjoy this conversation with Chadi Nabhan.

The following is a conversation with Dr Aaron Goodman, hematologist/oncologist at the University of California San Diego. What is good medical education? How do we best learn to communicate? What does twitter mean for medical science? Interview: Nico Gagelmann, Claire Horgan

The following is a conversation with Robert Panza, former policeman from California and volunteer stem cell courier for the National Marrow Donor Program in the United States. We talk about the National Marrow Donor Program, how Robert got into being a stem cell courier, what it means, funny and sad stories, challenges and wonders since the pandemic. Interview: Nico Gagelmann (https://twitter.com/NicoGagelmann) MORE about our Trainee Committee on https://twitter.com/TheEBMT_Trainee https://www.ebmt.org/trainee-committee MORE about EBMT on https://www.ebmt.org/ https://twitter.com/TheEBMT Robert Panza is also one of about 200 people across the USA who are volunteer NMDP Ambassadors, advocating on behalf of cellular therapy patients and the NMDP with elected officials. Wherever you are, please register as a donor to further reduce the current inequalities of donor access. Go visit the https://network.bethematchclinical.org/ https://bethematch.org/ https://www.anthonynolan.org/ https://www.dkms.org/ More on being a courier in COVID times https://twitter.com/i/status/1324440879902371841

Bronwen Shaw is MD and Professor at the Froedtert and the Medical College of Wisconsin and the current president of the World Marrow Donor Association (WMDA), which is made up of organisations and individuals who promote global collaboration and best practices for the benefit of stem cell donors and transplant patients. WMDA was informally initiated in 1988 by three pioneers in the field of transplantation: John Goldman (United Kingdom), E. Donnall Thomas (United States) and Jon J. van Rood (the Netherlands). This led to the foundation of WMDA in 1994. In 2007, WMDA became one of the founding members of the Worldwide Network for Blood and Marrow Transplantation (WBMT). WBMT is a non-profit scientific organisation which aims to promote excellence in stem cell transplantation, donation and cellular therapy. It has an official relationship with the World Health Organization. The other three founding organisations of the WBMT are the European Society for Blood and Marrow Transplantation (EBMT), the Center for International Blood & Marrow Transplant Research (CIBMTR), and the Asian Pacific Blood and Marrow Transplantation Group (APBMT). Interview: Nico Gagelmann MORE about our Trainee Committee on https://twitter.com/TheEBMT_Trainee https://www.ebmt.org/trainee-committee MORE about EBMT on https://www.ebmt.org/ https://twitter.com/TheEBMT MORE about the WMDA on h ttps://wmda.info/ https://twitter.com/WMDA_office

Prof Stanley Riddell is a world leader in developing immunotherapies using adoptive T cell therapy. Fasten your seatbelt and enjoy this rush from basic research to clinical reasoning.

Dr. Lan-Lan Smith on the process after a manuscript got submitted.

Dr. Lan-Lan Smith is founding editor of The Lancet Haematology and former senior editor of The Lancet Oncology. This conversation is about science, its communication and publication, scientific review process, and The Lancet journal family.

Gösta Gahrton on important milestones of stem cell transplantation and cellular therapy.

Gösta Gahrton reflecting on the beginnings and evolution of EBMT.

Gösta Gahrton on the history of stem cell transplantation and his first experiences.

Gösta Gahrton on Nobel Prize procedures and the year 1990.

Gösta Gahrton is Professor of Medicine at Department of Medicine, Huddinge, Karolinska Institute, Sweden. He was Head of Hematology at Huddinge Hospital and Head of the Department of Medicine Karolinska Institutet, where he established one of the first bone marrow transplantation centers. Prof Gahrton has been a member and chairman of the Nobel Committee of the Karolinska Institutet.